CXCR4 and breast cancer: Again, in breast cancer, ACKRs that scavenge CXCL12 limited tumor growth and metastasis in CXCR4+ breast cancer cells possibly due to reduced neovascularization or disruption of CXCL12-guided egress through tumor-associated lymphatic vessels [120].